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Harmane, a potent neurotoxin linked with several neurological disorders, is present in many foods, coﬀe e ,a n dc i g a r e t t e s .W e
assessed whether morning food/coﬀee consumption and smoking were reﬂected in blood harmane concentrations (BHCs) we
obtained in an epidemiologic sample (n = 497). Participants who smoked on the morning of phlebotomy had similar logBHCs
to those who had not smoked (P = .5 7 ) ;t h e r ew a sn oc o r r e l a t i o nb e t w e e nl o g B H C sa n dn u m b e ro fc i g a r e t t e s( P = .59). Among
the coﬀee drinkers, there was no correlation between number of cups and logBHCs (P = .98). Participants who had eaten on the
morning of phlebotomy had similar logBHCs to those who had not (P = .49); logBHCs did not correlate with the time latency
between last food consumption and phlebotomy (P = .74). BHCs in this sample of ∼500 individuals did not covary with recent
smoking, coﬀee, or food consumption, suggesting that our inability to withhold these exposures on the morning of phlebotomy
was not reﬂected in the BHCs we measured.
1.Introduction
Harmane (1-methyl-9H-pyrido[3,4-β]indole) is a potent
neurotoxin that has been linked with several neurological
outcomes [1, 2]. Although it is produced endogenously
by the body, harmane is also present in many foods (esp.
meats but also plant-derived foods) [3]. Studies have shown
that harmane concentrations are particularly high in certain
commonly consumed beverages (esp. coﬀee) [3–6]a sw e l l
as cigarettes [3, 5, 7]. Coﬀee consumption and smoking are
widespread and common human behaviors.
Smoking [8] and food ingestion [9] have been shown to
result in transient elevations in BHCs. After smoking, blood
harmane levels rise rapidly and seem to return to baseline
within one hour, although the number of tested human
volunteers has been small (n = 3) [8]. After oral dosing
(harmane dissolved in corn oil), blood harmane levels in
rats peaked rapidly (in approximately 30 minutes) and then
gradually returned to baseline within 3–5 hours [9].
Studies of harmane and its relation to neurological
outcomes (essential tremor [ET] and Parkinson’s disease)
often involve work with frail and elderly study subjects
for whom fasting on the morning of testing is not fea-
sible, especially as many of these patients must also take
prescription medications (often accompanied with food).
It is also diﬃcult to ask smokers to refrain, and their
attempts to do so can transiently exacerbate their tremor,
confounding the accurate assessment of tremor severity.
Given these limitations, it is important to know whether
food consumption, coﬀee consumption, and/or smoking on
the morning of phlebotomy are reﬂected in blood harmane
concentrations (BHCs).2 Journal of Toxicology
Our overarching question was whether morning
food/coﬀee consumption and smoking were reﬂected in
the BHCs we obtained. The speciﬁc questions we asked
were the following. (1) Did participants who smoked on
the morning of phlebotomy have higher BHCs than those
who did not smoke? (2) Was the the number of cigarettes
smoked on the morning of phlebotomy correlated with
BHCs? (3) Did participants who consumed coﬀee on the
morning of phlebotomy have higher BHCs than those
who did not? (4) Was the number of cups of coﬀee on the
morning of phlebotomy correlated with BHCs? (5) Was
there a correlation between the time of last food ingestion
and BHCs? If these questions were answered aﬃrmatively,
this would suggest that these exposures are important to
consider when assessing case-control diﬀerences in BHCs.
If not, it would suggest that these exposures are relatively
unimportant in this context. Using data from a large
epidemiological study of ET, we evaluated these exposures
in approximately 500 individuals. In addition to BHCs,
information on smoking, coﬀee consumption, and food
intake on the morning of phlebotomy were available.
2. Methods
2.1. Participants. All participants were enrolled between
June 2000 and May 2008 in a study of the environmental
epidemiology of tremor at Columbia-University Medical
Center (CUMC). Participants consisted of ET cases and
controls. By design, ET cases were identiﬁed from several
sources; the major ones were a computerized billing database
ofpatientsattheNeurologicalInstituteofNewYork,CUMC,
and the International Essential Tremor Foundation, whose
members were mailed advertisements [2, 10]. All cases had
received a diagnosis of ET from their treating neurologist
and lived within two-hour driving distance of CUMC in
the New York Metropolitan area. Based on a videotaped
tremor examination, described below, their diagnoses were
conﬁrmed by a senior movement disorder neurologist
(E.D.L.) using published diagnostic criteria (moderate or
greater amplitude action tremor during ≥3 activities or a
head tremor in the absence of Parkinson’s disease, dystonia,
or another neurological disorder) [10–12].
Normal control subjects were also recruited during the
same time period [2, 10] .T h e s ec o n t r o l sw e r ei d e n t i ﬁ e d
using random digit telephone dialing within a deﬁned set of
telephone area codes in the New York Metropolitan area that
were represented by the ET cases. Controls were frequency
matched to cases based on gender, race, and current age.
The CUMC Internal Review Board approved of all
study procedures, and signed written informed consent was
obtained from all participants upon enrollment [2, 10].
Of 698 ET cases and controls enrolled, complete data
were available in 497 (71.2%). The majority of the remaining
participants had refused phlebotomy or had had an unsuc-
cessful phlebotomy attempt. The ﬁnal sample of 497 was
similar to the base sample of 698 in terms of age (mean ±
standard deviation = 66.0 ± 14.4v e r s u s6 7 .2 ± 14.2y e a r s ,
t = 1.43, and P = .15), gender (267 [53.7%] versus 376
[53.9%] female, chi-square = 0.00, and P = .96), years of
education (15.4 ± 3.5v e r s u s1 5 .3 ± 3.5y e a r s ,t = 0.49, and
P = .63), and proportion who were current smokers (43
[8.7%] versus 57 [8.2%]) chi-square = 0.09, and P = .77).
2.2. Clinical Evaluation. All participants were evaluated in
person by a trained tester. The tester administered clinical
questionnaires and performed a videotaped tremor exami-
nation and phlebotomy.
As noted above, most evaluations were home visits and,
therefore, were performed in the late morning, making
fasting BHCs impractical.
The tester used a structured questionnaire to collect
demographic information including age in years, gender,
race, years of education, current smoker (yes versus no), the
numberofcigarettessmokedperday,cigarettepackyears,the
numberofcigarettessmokedonthemorningofphlebotomy,
and the number of cups of coﬀee consumed on the morning
of phlebotomy. Several years into the study, questions were
added as to whether food was consumed on the morning
of phlebotomy and the number of hours between last food
consumption and the phlebotomy. Similar data on number
of hours between smoking or coﬀee consumption and
phlebotomy were not available. Medical comorbidity was
assessed with the cumulative illness rating scale (range = 0–
42 (high comorbidity)) [13].
The tester videotaped a tremor examination in all
participants [10, 12]. Each of 12 videotaped action tremor
items was rated by a senior movement disorder neurologist
(E.D.L.) on a scale from 0 (none) to 3 (severe tremor)
[10–12].
2.3. BHCs. At the time of the evaluation, phlebotomy was
performed. When the evaluation was performed in the par-
ticipant’s home, blood samples were temporarily stored on
ice packs and then several hours later transferred to a −20◦C
freezer; if performed at CUMC, they were placed immedi-
ately into a −20◦C freezer. Blood harmane concentrations
were measured blinded to all clinical information with a
well-established high-performance liquid chromatography
methoddescribedindetailinourpreviousstudies[2,10,14].
The intraday precision, measured as a coeﬃcient of variation
at25ng/mL,was6.7%.Theinterdayprecisionwas7.3%[14].
Our method uses whole blood rather than plasma. Harmane
is highly lipophilic, accumulating inside of blood cells, with
published studies demonstrating low relative recovery of
harmane from plasma [9, 14].
2.4. Statistical Analyses. Statistical analyses were performed
in SPSS (Version 18.0). The empirical distribution of BHCs
was positively skewed (one-sample Kolmogorov-Smirnov
test, z = 9.37, P<. 001), even after log transformation
(one-sample Kolmogorov-Smirnov test, z = 2.37, P<. 001).
Hence, nonparametric tests (Mann Whitney U, Kruskal-
Wallis, Spearman’s rho) were used when assessing this
variable. For smoking, pack years was assigned the value “0”
for nonsmokers. We stratiﬁed participants based on tertiles
of cigarettes smoked on the morning of phlebotomy. ForJournal of Toxicology 3
Table 1: Characteristics of 497 study participants.
Age (years) 66.0 ±14.4
Female gender 267 (53.7)
White race 445 (89.5)
Education (years) 15.4 ±3.5
Cumulative illness rating scale score 5.3 ±3.7
Current smoker 43 (8.7)
Number of cigarettes smoked per day (smokers only) 18.8 ±17.0
Cigarette pack years 10.8 ±20.9
Smoked on morning of phlebotomy 43 (8.7)
Number of cigarettes smoked on morning of
phlebotomy
0.4 ±1.5
Drank coﬀee on morning of phlebotomy 214 (43.1)
Number of cups of coﬀee on morning of phlebotomy 0.7 ±1.0
Log blood harmane concentration in g−10/ml 0.45 ±0.60
Values are means ± standard deviation or number (percent).
coﬀee consumption, we dichotomized participants based on
highest consumption level (≥4 cups per day).
To assess potential confounding variables (e.g., educa-
tion), stratiﬁed analyses were performed.
3. Results
3.1. Introduction. The 497 participants (242 ET cases and
255 controls) had a mean age of 66.0 ± 14.4y e a r s( Table 1).
Of the 497, 43 (8.7%) had smoked on the morning of phle-
botomy(0.4 ±1.5,range =0–13cigarettes),and214(43.1%)
h a dc o n s u m e dc o ﬀee on the morning of phlebotomy (0.7 ±
1.0, range = 0–5 cups). The mean log BHCs was 0.51 ±
0.56g−10/mLinETcasesand0.38±0.63g−10/mLincontrols,
ad i ﬀerence that was statistically signiﬁcant (Mann Whitney
P = .01). The non-log-transformed BHCs was 11.49 ±52.05
(median = 2.49) g−10/ m Li nE Tc a s e sa n d1 0 .42 ± 56.16
(median = 1.81)g−10/mL in controls. Log BHCs were not
associated with age (Spearman’s r = 0.02, P = .68), gender
(Mann Whitney P = .80), white race (Mann Whitney P =
.96), or cumulative illness rating scale score (Spearman’s
r =− 0.001, P = .99), but they were weakly and inversely
associated with years of education (Spearman’s r =− 0.09,
P = .04).
3.2. Smoking. Current smokers did not diﬀer from current
nonsmokers in terms of log BHCs (0.39 ± 0.52 [median =
0.20] versus 0.44 ± 0.62 [median = 0.34], Mann Whitney
z = 0.64, P = .52). Additionally, neither cigarette pack
years (Spearman’s r =− 0.04, P = .4 2 )n o rn u m b e ro f
cigarettes smoked per day (Spearman’s r = 0.04, P = .82)
were correlated with log BHCs.
Participants who smoked on the morning of phlebotomy
had similar log BHCs to those who had not smoked
on that morning (0.41 ± 0.51 [median = 0.30] versus
0.45 ± 0.61 [median = 0.34], Mann Whitney z = 0.58,
P = .57). There was no correlation between log BHCs
and the number of cigarettes smoked on the morning of
phlebotomy (Spearman’s r =− 0.03, P = .59), even after
restrictingtheanalysestothe43participants whosmokedon
the morning of phlebotomy (Spearman’s r = 0.10, P = .54).
Highsmokers(i.e.,the15participantswhowereintheupper
tertile of cigarettes smoked on the morning of phlebotomy,
i.e., ≥5 cigarettes) had similar log BHCs to the participants
who had not smoked on the morning of phlebotomy (0.51±
0.54 [median = 0.20] versus 0.45 ± 0.61 [median = 0.34],
Mann Whitney z = 0.20, P = .84).
Yearsofeducation,whichwereassociatedwithlogBHCs,
were inversely associated with number of cigarettes smoked
on the morning of phlebotomy (Spearman’s r =− 0.12,
P = .008). Therefore, participants were stratiﬁed based on
median years of education into a high (≥16 years) versus low
(<16 years) education group; within these education strata,
there was no diﬀerence in the log BHCs between participants
who had versus who had not smoked on the morning of
phlebotomy (for high education stratum, Mann Whitney z
= 0.92, P = .36; for low education stratum, Mann Whitney
z = 0.05, P = .96). Participants were also stratiﬁed into
those who had versus those who had not consumed coﬀee
onthemorningofphlebotomy;withinthesestrata,therewas
no diﬀerence in the log BHCs between participants who had
versus who had not smoked on the morning of phlebotomy
(for coﬀee drinkers, Mann Whitney z = 0.31, P = .76; for
nondrinkers, Mann Whitney z = 0.90, P = .37). Finally,
participants were stratiﬁed into cases versus controls; within
these strata, there was no diﬀerence in the log BHCs between
participants who had versus who had not smoked on the
morning of phlebotomy (for cases, Mann Whitney z = 1.21,
P = .23; for controls, Mann Whitney z = 0.30, P = .76).
3.3. Coﬀee. Participants who drank coﬀee on the morning
of phlebotomy had a marginally lower log BHCs than those
who had not had coﬀee on that morning (0.39 ± 0.59
[median = 0.29] versus 0.49 ± 0.61 [median = 0.38],
Mann Whitney z = 1.82, P = .069). ET cases had
higher blood harmane than controls and, presumably to
avoid exacerbating their tremor, also drank less coﬀee than
controls. After stratifying by case-control status, drinking
coﬀee on the morning of phlebotomy did not seem to be
associated with higher log BHCs (Table 2).
In the combined sample of cases and controls, there
was a marginal inverse correlation between log BHCs and
the number of cups of coﬀee consumed on the morning
of phlebotomy (Spearman’s r =− 0.08, P = .08) but
not when analyses were restricted to the 214 participants
who had consumed coﬀee on the morning of phlebotomy,
Spearman’s r = 0.002, P = .98. High coﬀee consumers
(i.e., the 11 participants who drank ≥4c u p so fc o ﬀee on
the morning of phlebotomy) had marginally lower log BHCs
than participants who had not had coﬀee on the morning of
phlebotomy (0.38 ± 0.66 [median = 0.29] versus 0.49±0.61
[median = 0.38], Mann Whitney z = 1.72, P = .085).
After stratifying by case-control status, there was a marginal,
weak, inverse association between the number of cups of4 Journal of Toxicology
Table 2: Log blood harmane concentration and coﬀee consumption in analyses stratiﬁed by case-control status.
ET cases (N = 242) Controls (N = 255)
Log blood harmane concentration (g−10/ml)
Drank coﬀee on morning of phlebotomy 0.42 ±0.54 [0.34] 0.37 ±0.62 [0.28]
Did not drink coﬀee 0.56 ±0.57 [0.42] 0.40 ±0.65 [0.26]
P = .11a P = .69a
Correlation between the number of cups of coﬀee on morning of
phlebotomy and log blood harmane concentration
r =− 0.012, P = .068 r =− 0.002, P = .97
Correlation between the number of cups of coﬀee on morning of
phlebotomy and log blood harmane concentration (in 214
participants who drank coﬀee on the morning of phlebotomy)
r =− 0.014, P = .23 r = 0.078, P = .38
aMann Whitney test. In upper row, values are means ± standard deviation (median). Correlation coeﬃcients, r,a r eS p e a r m a n ’ sr h o .
Table 3: Log blood harmane concentrations by categories of time
lapse (hours) between food consumption and phlebotomy.
Time lapse (hours)
between food consumption
and phlebotomy
N
Log blood harmane
concentration
(g−10/ml)
≤1 31 0.20 ± 0.42 [0.19]
>1t o2 30 0.33 ± 0.34 [0.38]
>2t o3 31 0.40 ± 0.53 [0.40]
>3t o4 12 0.10 ± 0.33 [0.06]
>4 5 0.26 ± 0.38 [0.19]
Values are means ± standard deviation (median).
coﬀee and log BHCs in cases only but not when the analyses
were restricted to the participants who had had coﬀee on the
morning of phlebotomy (Table 2).
Yearsofeducation,whichwereassociatedwithlogBHCs,
were not associated with the number of cups of coﬀee
consumed on the morning of phlebotomy (Spearman’s r =
0.008, P = .86).
3.4. Food Consumption. Data were available on food con-
sumptiononthemorningofphlebotomyin215participants,
of whom 196 (91.2%) had eaten on the morning of
phlebotomy. The 196 participants who had eaten on the
morning of phlebotomy had similar log BHCs to the 19
who had not eaten (0.35 ± 0.44 [median = 0.33] versus
0.34 ± 0.47 [median = 0.24], Mann Whitney z = 0.70, and
P = .49). After stratifying by case-control status, the results
were similar in cases: (0.42 ± 0.47 [median = 0.38] in 115
eaters versus 0.37 ± 0.47 [median = 0.24] in 7 noneaters,
Mann Whitney z = 0.48, and P = .63) and in controls
(0.25 ± 0.39 [median = 0.26] in 81 eaters versus 0.32 ± 0.48
[median = 0.24] in 12 noneaters, Mann Whitney z = 0.18,
and P = .86).
Data were available for 109 participants on the time lapse
between last food consumption and phlebotomy. The mean
lapse was 2.0 ± 1.1 hours [median = 1.8], range = 0–5.5
hours. There was no correlation between the duration of
this time lapse and log BHCs (Spearman’s r = 0.03, P =
.74). After stratifying by case-control status, the results were
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Figure 1: Hours between food consumption and phlebotomy (x
axis) and log blood harmane concentration (g−10/ml) (y axis).
Regression line is shown (Spearman’s r = 0.03, P = .74).
similar (Spearman’s r = 0.13, P = .36 among 51 controls;
Spearman’s r =− 0.02, P = .91 among 58 cases).
In the 109 participants, we stratiﬁed the time lapse
into hourly categories, and log blood harmane was similar
in participants who had eaten one hour or less prior to
phlebotomy and participants who had eaten 2, 3, 4, 5, or
more hours prior to phlebotomy (Kruskal-Wallis P = .19,
Table 3, Figure 1).
4. Discussion
Harmane is a beta-carboline alkaloid that has been linked
with several neurological diseases [1, 2], making this potent
neurotoxin of etiological interest in these diseases. Yet,
studies of harmane and its relation to neurological diseases
such as ET and Parkinson’s disease generally require work
with elderly subjects who are fragile or in poor health
and for whom fasting blood levels are either impractical
or simply not possible. Furthermore, withholding cigarettes
can increase anxiety and discomfort, thereby exacerbating
tremor and confounding the accurate assessment of tremor
severity. These practical limitations lead to the researchJournal of Toxicology 5
question whether food consumption, coﬀee consumption,
and/or smoking, which often occur on the morning of
phlebotomy, inﬂuence BHCs. The current dataset allowed us
to examine this set of questions in a sample of approximately
500 study participants with both exposure data on these
lifestyle characteristics and data on BHCs.
We found that participants who had smoked on the
morning of phlebotomy had similar BHCs to their counter-
partswhohadnotsmokedthatmorning.Furthermore,there
was no detectable association between dosage of exposure
to cigarettes on the morning of phlebotomy and BHCs. A
cautionary note is that we did not collect blood samples
within one hour of smoking, and, as discussed in detail
below, this could have accounted for the lack of association
between smoking and BHCs. For coﬀee consumption, there
was only a very marginal inverse relationship with BHCs,
but this was not consistent and, hence, of questionable
signiﬁcance. Finally, in the subsample of participants with
timed data on food consumption, there was no discernable
correlation between the time of the last food ingestion and
BHCs. These results were observed in parallel in normal
controls as well as in a group of ET patients.
How do our results relate to those from prior studies?
After smoking, blood harmane levels rise rapidly and seem
to return to baseline within one hour [8], which suggests
that the rise is transient and time limited. In another
study of 39 human volunteers, plasma concentrations of
norharman (9H-pyrido[3,4-β]indole), a neurotoxin that is
structurally very similar to harmane, were on average several
fold higher when smokers were not restricted in terms of
smoking as compared to a condition in which the same
smokers had refrained from smoking for at least six hours
[15]. Another study [16], of 20 human volunteers, found a
positive correlation between number of cigarettes smoked
per day and plasma harmane concentration. It is possible
that participants in these two prior studies smoked with one
hour of phlebotomy, thereby resulting in acute elevations
in BHCs and a detectable correlation between smoking
behavior and BHCs. We did not collect data on the time
that our participants smoked, so we do not know how many
smokers smoked within one hour of phlebotomy. If most did
not, this could explain our null ﬁnding.
In rats, oral dosing of harmane (i.e., 110umol/kg har-
mane dissolved in corn oil) caused blood harmane levels
to peak rapidly (in approximately 30 minutes) and then
gradually return to baseline within 3–5 hours [9]. Yet, a
study involving humans showed a range of responses to
ingestion of ethanol or orange juice, including transient
declines and, in others, transient rises in BHCs, with these
transient changes ranging in duration from 1 hour to more
than 8 hours [17]. Hence, the eﬀects of food ingestion on
BHCs in humans are less clear than the eﬀects of oral dosing
of harmane in laboratory animals. Our current results did
not ﬁnd any association between food intake or time of food
intake and BHCs.
This study had limitations. This was not a pharma-
cokinetic study, and we did not assess pre- versus post-
consumption BHCs in order to directly test whether blood
concentrations rose. Furthermore, while in a subsample of
participants, we had data on the time latency between the
last food ingestion and phlebotomy, we had no data on the
time of the last cigarette use or coﬀee consumption and
phlebotomy, so for cigarettes and coﬀee, we were unable
to time lock the events to phlebotomy. Second, we limited
our assessment of smoking to cigarettes (i.e., inhaled smoke
products) rather than pipe smoke or chewing tobacco,
which were rare. Third, we did not assess whether diﬀerent
brands of coﬀee or cigarettes or diﬀerences in cooking styles
inﬂuenced the BHCs we observed. The study also had several
strengths. First, both BHCs and clinical data were assessed in
the same study sample, comprising a collection of nearly 500
individuals. Second, for smoking, we presented both histori-
caldataforthedegreeoftheirregularconsumptionaswellas
data on acute consumption on the morning of phlebotomy.
Third, the results were observed in normal controls and then
reproduced in ET patients. Fourth, most published studies
determined harmane concentrations in plasma, whereas
our study investigates harmane in whole blood. The latter
approach allows for a more accurate assessment of harmane
concentrationsbyincludingallbloodcompartments.Finally,
there is the uniqueness of the question; there are no other
studies that have examined this issue.
5. Conclusions
In summary, BHCs in this sample of nearly 500 individuals
did not covary with smoking, coﬀee consumption, or food
consumption, suggesting that our inability to withhold these
exposures on the morning of phlebotomy was not reﬂected
in the BHCs we measured.
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